Clinical Readouts
MBX Secures $63.5M in Funding Ahead of Clinical Readouts
MBX, clinical readouts, funding, engineered peptide therapeutics, hypoparathyroidism, Phase II trial
Actionable Insights Powered by AI
MBX, clinical readouts, funding, engineered peptide therapeutics, hypoparathyroidism, Phase II trial